Hematology and Oncology

Home Hematology and Oncology

2021 USPSTF Lung Cancer Screening Criteria Expand Eligibility

Compared with 2013 USPSTF criteria, more patients eligible for lung cancer screening with less racial disparity in access

Guideline Issued for External Beam RT in Primary Liver Cancers

EBRT strongly recommended as potential first-line therapy for patients with HCC confined to liver who are not candidates for curative therapy

Unnecessary RT Given Near End of Life in Metastatic Cancer

Guideline-nonconcordant radiotherapy given to substantial proportion of Medicare beneficiaries with metastatic cancer near the end of life

Global Burden of Chronic Lymphocytic Leukemia Up From 1990 to 2019

Incidence higher for men versus women, adults older than 70 years, and individuals living in high social-demographic index regions

Survival Increase Seen for Adults With Relapsed Ph+ ALL

From 2000 to 2019, overall survival progressively improved for patients with Philadelphia-positive ALL who had posttransplant relapse

Amid U.S. Blood Shortage, New Pressure to Ease Donor Rules for Gay Men

Easing the rules would result in a 2 to 4 percent increase -- 345,400 to 615,300 more pints of blood -- in the nation's annual blood supply

Senate Committee Backs Califf Nomination to Head FDA

Among those who voted against Califf's nomination were Democrats who expressed concerns about his links to pharmaceutical companies

Supreme Court Blocks Biden’s Vaccine Mandate for Large Employers

Mandate was a crucial component of the White House plan to tackle the COVID-19 pandemic

Data Support Lowering Age for CRC Screening to 45 Years

For those aged 45 to 49 years, 32 percent had any neoplasia, 7.5 percent had advanced premalignant lesions, 0.58 percent had CRC

NCCN Endorses Full COVID-19 Vaccination for Cancer Patients

The NCCN Advisory Committee supports the strong preference for mRNA vaccines and offers guidance on the timing of vaccination